SCHEMBL2903041

SCHEMBL2903041

N#Cc1ccc(Oc2cc[c]cn2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.43
CYP19A1 P11511 1/20 0.42
PARP15 Q460N3 1/20 0.40
PARP10 Q53GL7 1/20 0.40
PARP2 Q9UGN5 1/20 0.40
LMNA P02545 5/20 0.39
KDM4E B2RXH2 3/20 0.39
POLB P06746 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
IL18 Q14116 1/20 0.39
MAOB P27338 1/20 0.39
OPRM1 P35372 1/20 0.39
KCNH2 Q12809 1/20 0.38
SCN5A Q14524 1/20 0.38
SCN9A Q15858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2902939 0.81 MAP4K4 (0.48) MAP4K4KCNH2PDE4BJAK2JAK1
SCHEMBL2903058 0.79 MEN1 (0.44) MAP4K4LMNAKDM4EPOLBMEN1
SCHEMBL2899323 0.79 MAPT (0.39) KDM4EMEN1MAPTMAPK1KMT2A
SCHEMBL1712271 0.79 MEN1 (0.50) KDM4EMEN1KMT2ASMN1; SMN2HTT
SCHEMBL2894972 0.79 MEN1 (0.52) MAP4K4LMNAKDM4EPOLBMEN1
SCHEMBL2901814 0.79 L3MBTL1 (0.44) LMNAKDM4EMEN1MAPTMAPK1
SCHEMBL315475 0.78 ALDH1A1 (0.43) MAP4K4KDM4EMEN1MAPTMAPK1
SCHEMBL10393907 0.76 NPC1 (0.40) LMNAMEN1MAPTMAPK1RAB9A
SCHEMBL1222107 0.76 OPRM1 (0.50) MAP4K4CYP19A1KDM4EMEN1KMT2A
SCHEMBL919772 0.75 PARP15 (0.53) CYP19A1PARP15PARP10PARP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100305124-A1 Acylated Aminopyridine and Aminopyridazine Insecticides BAYER CROPSCIENCE AG (DE) 2010-12-02 US disclosed
EP-2236505-A1 Acylated aminopyridines and pyridazines as insecticides Bayer CropScience AG (DE) 2010-10-06 EP disclosed
US-6235758-B1 CENTRAL NERVOUS SYSTEM DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 2001-05-22 US disclosed
EP-0808312-B1 INDOLE DERIVATIVES AS 5-HT RECEPTOR ANTAGONIST SMITHKLINE BEECHAM PLC (GB) 2000-11-02 EP disclosed
US-5990133-A TREATING CENTRAL NERVOUS SYSTEM DISORDERS SUCH AS ANXIETY OR DEPRESSION SMITHKLINE BEECHAM P.L.C. (GB) 1999-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305124-A1 Acylated Aminopyridine and Aminopyridazine Insecticides AAAS, DDT, QDPR MAP4K4 2930/4885CYP19A1 726/4885PARP15 377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.